eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

Interview with Professor Janusz Skowronek
ABS 2015
vol. 9
Review paper

How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer

Matthew M. Harkenrider, Steven M. Shea, Abbie M. Wood, Bonnie Chinsky, Amishi Bajaj, Michael Mysz, Joseph H. Yacoub, Ari Goldberg, Margaret Liotta, Ronald Potkul, Murat Surucu, John Roeske, William Small Jr

J Contemp Brachytherapy 2017; 9, 2: 177–186
Online publish date: 2017/03/30
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Purpose: Adaptive magnetic resonance imaging (MRI)-based brachytherapy results in improved local control and decreased high-grade toxicities compared to historical controls. Incorporating MRI into the workflow of a department can be a major challenge when initiating an MRI-based brachytherapy program. This project aims to describe the goals, challenges, and solutions when initiating an MRI-based cervical cancer brachytherapy program at our institution.

Material and methods: We describe the 6-month multi-disciplinary planning phase to initiate an MRI-based brachytherapy program. We describe the specific challenges that were encountered prior to treating our first patient.

Results: We describe the solutions that were realized and executed to solve the challenges that we faced to establish our MRI-based brachytherapy program. We emphasize detailed coordination of care, planning, and communication to make the workflow feasible. We detail the imaging and radiation physics solutions to safely deliver MRI-based brachytherapy. The focus of these efforts is always on the delivery of optimal, state of the art patient care and treatment delivery within the context of our available institutional resources.

Conclusions: Previous publications have supported a transition to MRI-based brachytherapy, and this can be safely and efficiently accomplished as described in this manuscript.

brachytherapy, cervical cancer, image-based brachytherapy, MRI

GLOBOCAN Cervical Cancer Fact Sheet. Available at http:// globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp. Accessed: 12 January 2017.
Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-1143.
Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-1153.
Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gyne­cologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339-1348.
Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004; 22: 872-880.
Rose PG, Ali S, Watkins E et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study. J Clin Oncol 2007; 25: 2804-2810.
Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-1161.
Stehman FB, Ali S, Keys HM et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007; 197: 503 e501-506.
Walstam R. The dosage distribution in the pelvis in radium treatment of carcinoma of the cervix. Acta Radiol 1954; 42: 237-250.
Pierquin B. Precis de curietherapie, endocurietherapie et plesiocurietherapie. Masson, Paris 1964.
Tod M, Meredith W. A dosage system for use in the treatment of cancer of the uterine cervix. Br J Radiol 1938; 1: 809-824.
Haie-Meder C, Pötter R, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245.
Viswanathan AN, Dimopoulos J, Kirisits C et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007; 68: 491-498.
Perez CA, Breaux S, Madoc-Jones H et al. Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence. Cancer 1983; 51: 1393-1402.
Eifel PJ, Thoms WW, Jr., Smith TL et al. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 1994; 28: 113-118.
Viswanathan AN, Cormack R, Rawal B et al. Increasing bra­chy­therapy dose predicts survival for interstitial and tandem- based radiation for stage IIIB cervical cancer. Int J Gynecol Cancer 2009; 19: 1402-1406.
Tanderup K, Eifel PJ, Yashar CM et al. Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional. Int J Radiat Oncol Biol Phys 2014; 88: 537-539.
Shellock FG, Woods TO Crues JV, 3rd. MRI labeling information for implants and devices: explanation of terminology. Radiology 2009; 253: 26-30.
Expert Panel on MR Safety, Kanal E, Barkovich AJ, Bell C et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging 2013; 37: 501-530.
Hellebust TP, Kirisits C, Berger D et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-160.
Soliman AS, Owrangi A, Ravi A et al. Metal artefacts in MRI-guided brachytherapy of cervical cancer. J Contemp Brachytherapy 2016; 8: 363-369.
Hargreaves BA, Worters PW, Pauly KB et al. Metal-induced artifacts in MRI. AJR Am J Roentgenol 2011; 197: 547-555.
Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys 1996; 23: 815-850.
American Brachytherapy Society Meetings and Events. Available at: https://www.americanbrachytherapy.org/meetings/ index.cfm. Accessed: 24 January 2016.
EMBRACE Download PDF Protocol. Available at: https://www.embracestudy.dk/AboutProtocolDownload.aspx. Accesed: 6 December 2015.
Harkenrider MM, Alite F, Silva SR et al. Image-Based Bra­chytherapy for the Treatment of Cervical Cancer. Int J Radiat Oncol Biol Phys 2015; 92: 921-934.
Pötter R, Dimopoulos J, Georg P et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148-155.
Pötter R, Georg P, Dimopoulos JC et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-123.
Nesvacil N, Tanderup K, Hellebust TP et al. A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy. Radiother Oncol 2013; 107: 20-25.
Tanderup K, Nesvacil N, Potter R et al. Uncertainties in image guided adaptive cervix cancer brachytherapy: impact on planning and prescription. Radiother Oncol 2013; 107: 1-5.
Pötter R, Haie-Meder C, Van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
Fokdal L, Tanderup K, Hokland SB et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013; 107: 63-68.
EMBRACE. Available at: https://www.embracestudy.dk/About.aspx. Accessed: 11 January 2015.
Davidson MT, Yuen J, D’Souza DP et al. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance. Brachytherapy 2008; 7: 248-253.
Small W Jr., Strauss JB, Hwang CS et al. Should uterine tandem applicators ever be placed without ultrasound guidance? No: a brief report and review of the literature. Int J Gynecol Cancer 2011; 21: 941-944.
Viswanathan AN, Moughan J, Small W Jr et al. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer 2012; 22: 123-131.
Swanick CW, Castle KO, Rechner LA et al. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy 2015; 14: 385-389.
Dimopoulos JC, Petrow P, Tanderup K et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012; 103: 113-122.
Janaki MG, Nirmala S, Kadam AR et al. Epidural analgesia during brachytherapy for cervical cancer patients. J Cancer Res Ther 2008; 4: 60-63.
Isoyama-Shirakawa Y, Nakamura K, Abe M et al. Caudal epidural anesthesia during intracavitary brachytherapy for cervical cancer. J Radiat Res 2015; 56: 583-587.
Lanciano R, Corn B, Martin E et al. Perioperative morbidity of intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1994; 29: 969-974.
Kirchheiner K, Czajka-Pepl A, Ponocny-Seliger E et al. Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal/epidural anesthesia: incidence and risk factors. Int J Radiat Oncol Biol Phys 2014; 89: 260-267.
Dimopoulos JC, Potter R, Lang S et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009; 93: 311-315.
Brachytherapy Guidelines. Available at http://www.american-brachytherapy.org/guidelines/index.cfm. Accessed: 3 December 2016.
US Food and Drug Administration. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. June 20, 2014. Available at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm072686.htm. Accessed: 14 December 2016.
IEC 60601-1-1, Medical electrical equipment – part 2: particular requirements for the safety of magnetic resonance equipment for medical diagnosis. International Electrotechnical Commission (IEC), 2010.
Haack S, Nielsen SK, Lindegaard JC et al. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol 2009; 91: 187-193.
Kim Y, Muruganandham M, Modrick JM et al. Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer. Int J Radiat Oncol Biol Phys 2011; 80: 947-955.
Fedorov A, Beichel R, Kalpathy-Cramer J et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012; 30: 1323-1341.
Shea S, Diak A, Surucu M et al. Effect of Pulse Sequence Parameters on Geometric Distortions Induced by a Titanium Brachytherapy Applicator. Med Phys 2015; 42: 3313.
Chinsky B, Diak A, Small Jr W et al. Can Magnetic Resonance Imaging (MRI) Only Replace MRI-Computed Tomography Planning with a Titanium Applicator for Cervical Brachytherapy? Int J Radiat Oncol Biol Phys 2016; 96: S225-S226.
Gill BS, Kim H, Houser CJ et al. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: The University of Pittsburgh experience. Int J Radiat Oncol Biol Phys 2015; 91: 540-547.
Pötter R, Federico M, Sturdza A et al. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2016; 94: 588-597.
Tait LM, Hoffman D, Benedict S et al. The use of MRI deformable image registration for CT-based brachytherapy in locally advanced cervical cancer. Brachytherapy 2016; 15: 333-340.
Trifiletti DM, Libby B, Feuerlein S et al. Implementing MRI-based target delineation for cervical cancer treatment within a rapid workflow environment for image-guided brachytherapy: A practical approach for centers without in-room MRI. Brachytherapy 2015; 14: 905-909.
Owrangi AM, Prisciandaro JI, Soliman A et al. Magnetic resonance imaging-guided brachytherapy for cervical cancer: initiating a program. J Contemp Brachytherapy 2015; 7: 417-422.
Koulis TA, Doll CM, Brown D et al. Implementation and validation of a combined MRI-CT-based cervical cancer brachytherapy program using existing infrastructure. Brachytherapy 2016; 15: 319-326.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe